chevron_leftBack
As of 14 June 2026, Theragen Etex Co.,Ltd. has a market cap of $73.33M USD, ranking #27777 globally and #1436 in South Korea.
It ranks #2503 in the Healthcare sector, and #900 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$73.33MUSD
111.52B KRW
Enterprise Value
$89.13MUSD
135.31B KRW
Revenue (TTM)
$178.58MUSD
271.59B KRW
EBITDA (TTM)
$10.99MUSD
16.69B KRW
Net Income (TTM)
$6.97MUSD
10.6B KRW
EBITDA Margin
6.1%
Profit Margin
3.9%
PE Ratio
10.5
PS Ratio
0.4
PB Ratio
0.7
EV/EBITDA
8.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ko Jin-Up
open_in_new
Employees
224
Founded
1987
Website
theragenetex.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.5% | 1.5% | 9.4% | 2.7% | 17% | 2.5% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
066700
(주)테라젠이텍스
ISIN: KR7066700006
Shares Out.:
Shares Outstanding:
36.683M1
Shares Float:
27.294M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,040 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Theragen Etex Co.,Ltd.
Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd. and changed its name to Theragen Etex Co.,Ltd. in July 2010. Theragen Etex Co.,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
12K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
9K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
7K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
7K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
6K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
6K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
746K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
492K%
|
97.4
|
|
SIX: RO
|
$321.52B
438K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
394K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
374K%
218.9B CHF
|
20.5
|
chevron_leftBack